Results of the September 2016 Impact Grants competition

We are pleased to announce the results of the most recent Impact Grants competition. This program has been designed to accelerate and focus the knowledge gained from scientific findings, in the short or long term, into outcomes that will significantly advance understanding of cancer and improve scientific knowledge, which will result in optimized patient care, improved cancer treatment or reduced cancer burden. Below is a listing of newly awarded Canadian Cancer Society (CCS) Impact Grants.

5 Canadian Cancer Society Impact Grants have been approved – 28% of all full proposals received. 59 Letters of Intent were submitted to the competition, and following a scientific review 19 of these were invited to submit full applications, and 18 were received. This flagship program represents the largest project funding to individual investigators awarded by the Canadian Cancer Society. Grants are valued at up to $1.25M over a 5-year term. These 5 new grants represent a significant investment of almost $6 million.

The Canadian Cancer Society and Brain Canada have partnered to support an Impact Grant focused on brain cancer research in this competition. This partnership leverages donations made to the Canadian Cancer Society with matching funds from Brain Canada through the Canada Brain Research Fund, a public-private partnership established by the Government of Canada, enabling more brain cancer research to be funded.

The Cole Foundation and CCS Quebec division initiated the Mont Gabriel Summit Research Fund to fund research grants in the area of pediatric and young adult leukemia and lymphoma research. An Impact grant is being funded in this competition. Significant contributors to the Fund are: Molson Foundation, R. Howard Webster Foundation, Mirella and Lino Saputo Foundation, Fonds de recherche du Québec - Santé, Faculté de médecine, Université de Montréal, Letko Brosseau, Birks Family Foundation, Maryse and William Brock, CHU Sainte-Justine Foundation, Montreal Children’s Hospital Foundation, Morris and Rosalind Goodman Family Foundation, Zeller Family Foundation, David H. Laidley Foundation, Drummond Foundation,  and the Henry and Berenice Kaufmann Foundation.

Summaries of awarded grants

Please note: 

  • Amounts listed below represent the total dollars awarded by grant year and may include funds for salaries, supplies, and/or equipment.
  • The start date for these grants is February 1, 2017.
  • Only the Principal Investigator is named in this listing. Co-Principal Investigators, Co-Applicants and/or Additional Authors may also be associated with these grants.


Note Carefully:

Although every effort has been made to ensure the accuracy of the listing below, this list does not constitute an "official" notification.

Successful applicants will be informed, in writing, with an official Notification of Award giving the details pertaining to their grant.

Applicant
Institution
Title
Award
Angers, Stephane
University of Toronto
Targeting the Wnt pathway in cancer with therapeutic antibodies
2017/2018 :  $245,004
2018/2019 :  $244,998
2019/2020 :  $244,998
2020/2021 :  $244,998
2021/2022 :  $244,998
Huang, Annie
The Hospital for Sick Children
Advancing biology-based therapies for rhabdoid brain tumours
*co-funded with Brain Canada with the financial support of Health Canada
2017/2018 :  $243,127
2018/2019 :  $243,121
2019/2020 :  $242,640
2020/2021 :  $242,640
2021/2022 :  $242,519
Meloche, Sylvain
Université de Montréal
A novel tyrosine kinase oncogenic signalling pathway with therapeutic potential in hepatocellular carcinoma
2017/2018 :  $245,000
2018/2019 :  $245,000
2019/2020 :  $245,000
2020/2021 :  $245,000
2021/2022 :  $245,000
Puts, Maria (Martine)
University of Toronto
Clinical and cost-effectiveness of a comprehensive geriatric assessment in Canadian elders receiving chemotherapy: the 5C study
2017/2018 :  $230,201
2018/2019 :  $241,524
2019/2020 :  $239,780
2020/2021 :  $189,311
Wilhelm, Brian
Université de Montréal
Systematic studies of human models of acute myeloid leukemia: establishing a pipeline for novel targeted therapeutics
*co-funded by CCS Quebec Division and The Cole Foundation and its funding partners of the Mont Gabriel Summit Research Fund
2017/2018 :  $250,000
2018/2019 :  $250,000
2019/2020 :  $250,000
2020/2021 :  $250,000
2021/2022 :  $250,000

Last modified on: February 6, 2017